SIRION Biotech is a prominent Contract Manufacturing Organisation (CMO/CDMO) specialising in the design and manufacture of viral vectors for cell and gene therapy research and preclinical development. The company excels in its active research and development in the areas of AAV (Adeno-Associated Virus) and LV (Lentivirus) vector optimisation, focusing on clinically compliant vector designs. SIRION Biotech is dedicated to enhancing upstream and downstream process development for the manufacture of AAV, AV (Adenoviral Vector), and Lentivirus, catering to the evolving needs of the pharmaceutical industry.

Services include:
- Viral vector development and optimisation
- Manufacture of AAV, AV, and Lentivirus
- Upstream and downstream process development
- Quality control and assurance
- Cold storage solutions
- Packaging and documentation services

SIRION Biotech plays a crucial role in advancing gene therapy by providing essential services that support the pharmaceutical industry's innovative initiatives. For more information, please visit sirion-biotech.com.